Chemical Dependency Relapse Pathways Relapse Prevention Medications
“Understanding the how, why, where and when.” Acknowledgements
La Hacienda Treatment Center
American Society of Addiction Medicine
National Institute on Drug Abuse Definition of Dependency
A primary, progressive biochemical, ppysychosocial, ,g genetically transmitted chronic disease of relapse who’s hallmarks are denial, loss of control and unmanageability.
Natural Rewards Elevate Dopamine Levels FOOD SEX 200 200 ne)ne) NAc shell iiii
150 150 utpututput n (% (% (% n n BaselBasel OOOO ooo o Copulation 100 100 15
Empty 10 oncentrationcentrati F f Basal DA f Basal DA f Basal DA C CCC 50 requency ooo o Box Feeding
% % 5 DA DA DA
0 0 006060 120 180 ScrScrScrScr Scr Scr BasFemale 1 Present Female 2 Present Time (min) Sample 1122334455667788 991010 11 12 13 14 15 16 17 Number Mounts Intromissions Ejaculations
Source: Di Chiara et al. Source: Fiorino and Phillips Effects of Drugs on Dopamine Levels
Accumbens COCAINE 1100 AMPHETAMINE Accumbens 1000 400 900 800 DA DA 300 eleaseelease Release Release DOPAC llll 700 DOPAC RRRR HVA 600 HVA 500 200 400
% of Basa of Basa % % 300 200 of Basal of Basal % % 100 100 0 001122334455 hr 0 001122334455 hr Time After Amphetamine Time After Cocaine
250 NICOTINE 250 Accumbens MORPHINE Dose (mg/kg) 200 Accumbens 200 0.5 Caudate 1.0 l Releasel Release ReleaseRelease
aaaa 150 252.5 150 10 100 100 % of% of Bas Bas % of Basal of Basal % %
0 00112233 hr 0 00112233445hr5hr Time After Nicotine Time After Morphine
Source: Di Chiara and Imperato Dopamine Transporters in Methamphetamine Abusers
2.4
2.2 rs ee 2.0
1.8 /Kd) ansport rr Normal Control xx 161.6
1.4 (Bma
amine T 1.2 pp
Do 1.0 Normal Meth Controls Abusers Methamphetamine Abuser p < 0.0002
Methamphetamine abusers have significant reductions in dopamine
transporters. BNL --UCLAUCLA -SUNY NIDA - ONDCP - DOE Dopamine Transporters in Methamphetamine Abusers
Motor Task 2.0 1.8 Loss of dopamine transporters 1.6 in the meth abusers may result 1.4 in slowing of motor reactions.
sporter 1.2 nn 1.07 8 9 10 11 12 13 Time Gait (seconds) mine Tra Bmax/Kd aa 2.0 Dop Memory Task 1.8 1.6 Loss of dopamine transporters 1.4 ithin the meth thb abusers may resu lt 1.2 in memory impairment. 1.0 16 14 12 10 8 6 4 Delayed Recall (words remembered) BNL/UCLA/SUNY NIDA, ONDCP, DOE Dopamine D2 Receptors in Addiction
Control Experimental groups groups Cocaine
Meth
Alcoh o l
Food
Addictions
Hypothalamic Dysregulation
Impacts other areas of the brain including the Prefrontal Cortex , Cingulate and Pre- cingulate Gyrus, the Hippocampus, and the Amygdala .
Cha llenge: Normal Drug Use Addiction Treatment Three Major Relapse Pathways
I. Cross Addicting Drugs II. People/Place/Things III. BHALTB.H.A.L.T. Cross Addicting D rugs
a. Chemical of choice b. Related drugs c. TbTobacco d. Life long relapse pathway Effects of Drugs on Dopamine Levels
Accumbens COCAINE 1100 AMPHETAMINE Accumbens 1000 400 900 800 DA DA 300 eleaseelease Release Release DOPAC llll 700 DOPAC RRRR HVA 600 HVA 500 200 400
% of Basa of Basa % % 300 200 of Basal of Basal % % 100 100 0 001122334455 hr 0 001122334455 hr Time After Amphetamine Time After Cocaine
250 NICOTINE 250 Accumbens MORPHINE Dose (mg/kg) 200 Accumbens 200 0.5 Caudate 1.0 l Releasel Release ReleaseRelease
aaaa 150 252.5 150 10 100 100 % of% of Bas Bas % of Basal of Basal % %
0 00112233 hr 0 00112233445hr5hr Time After Nicotine Time After Morphine
Source: Di Chiara and Imperato Cross Addicting D rugs
a. Chemical of choice b. Related drugs c. TbTobacco d. Life long relapse pathway Chemicals of Choice
Cannot be a social or recreational user
Cannot use in a different form or method
Cannot use “just on special occasions”
CCtPERIODannot use PERIOD CossCross-Addicting Chemicals
Impact on the hypothalamus as the drug of choice
Usually leads back to the drug of original dependency
Life long relapse pathway Pain Cont rol in Addiction
Opiates are high risk in addictions
Non Steroidal Anti-inflammatories are safe
Some skeletal muscle relaxers are safe
Phys ical th erapy, st ret c hing, exerci se and massages are helpful
Having a target for pain control or reduction Anxiet y in Addictions
Benzodiazepines are rarely safe to use
SSRI’s can be used for Anxiety Disorders
Other AntiAnti--DepressantDepressant Classes can also be helpful in Anxiety Disorders
Meditation and Relaxation Techniques
EXERCISE Sleep in Addictions
Do not recommend hypnotic agents
Go to bed at the same time every night
No caffeine within 6 hours of bedtime
Nlithi3hfbdtiNo meals within 3 hours of bedtime
No exercise within 3 hours of bedtime
Use the bed only for sleep. Tobacco
23% of Americans are addicted to tobacco
>90% of the addicted population use tobacco
Tobacco Cessation MUST be encouraged
Relapse rates vary from 2 times to 5 times greater in a ddic ts w ho con tinue t o use tobacco People/Place/Things
a. Hist ory of discovery b. Three month limit for relapse
BHALTB.H.A.L.T.
All appear to be stress mediated
Relation to the Amygdala , the H -P-AAxisA Axis, and the release of CRF
Reduces with time as well
BHALTB.H.A.L.T.
a. Boredom b. Hunger c. Anger/emotions d. Loneliness e. Tiredness Relapse P re v ention Medications
I. Antabuse II. Campral III. RViReVia IV. Vivitrol V. Off label Antabuse
a. Mechanism of action b. Dosing c. Side Effects d. Efficacy Campral
a. Mechanism of action b. Dosing c. Side Effects d. Efficacy ReVia
a. Mechanism of action b. Dosing c. Side Eff ec ts d. Efficacy Vivit rol
a. Mechanism of action b. Dosing c. Side Effects d. Efficacy Off label Du al Diagnosis
1. Prevalence 2. Testing 3. Treatment Spiritual Component of Recovery Dr. Daniel Boone La Hacienda Treatment Center 800800--749749--61606160 dboone@l ah aci end a.com